Performance analysis of Telix Pharmaceuticals (TLX)
Annual Return
Since Nov 14, 2024, TLX has had an average annual return of -29.71%, underperforming the benchmark SPY, which returned +18.07% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +17.09% | -51.36% | +1.65% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.81% | -0.42% | +32.02% | +14.94% | -14.28% | -6.99% | +17.09% | ||||||
| 2025 | +20.78% | -3.33% | -6.78% | +3.81% | -2.36% | -5.41% | -15.43% | -29.72% | +0.21% | +11.38% | -6.65% | -24.73% | -51.36% |
| 2024 | +8.86% | -6.62% | +1.65% |
Drawdown analysis of Telix Pharmaceuticals (TLX)
The maximum drawdown for the TLX was -69.37%, occurring on Feb 18, 2026. This drawdown has not yet recovered.
The current TLX drawdown is -58.10%.
Since Nov 14, 2024 TLX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -69.37% | Feb 24, 2025 | 247 | Feb 18, 2026 | Ongoing | Ongoing | Ongoing |
| -12.81% | Dec 6, 2024 | 23 | Jan 13, 2025 | 4 | Jan 17, 2025 | 27 |
| -9.04% | Feb 4, 2025 | 8 | Feb 14, 2025 | 4 | Feb 21, 2025 | 12 |
| -3.92% | Nov 19, 2024 | 3 | Nov 22, 2024 | 2 | Nov 26, 2024 | 5 |
| -2.99% | Nov 29, 2024 | 4 | Dec 5, 2024 | 1 | Dec 6, 2024 | 5 |
| -2.10% | Jan 29, 2025 | 1 | Jan 30, 2025 | 1 | Jan 31, 2025 | 2 |
| -1.98% | Nov 14, 2024 | 1 | Nov 15, 2024 | 2 | Nov 19, 2024 | 3 |
| -1.29% | Jan 31, 2025 | 1 | Feb 3, 2025 | 1 | Feb 4, 2025 | 2 |
| -1.26% | Jan 24, 2025 | 1 | Jan 27, 2025 | 2 | Jan 29, 2025 | 3 |